Discover 1,294 paid clinical trials in Scottsdale, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,294
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
for
Breast Cancer, Metastatic Breast Cancer, Breast Neoplasm,
Location: Phoenix AZ, Tucson AZ, San Diego CA, Riverside CA,
Sponsor: BriaCell Therapeutics Corporation
Sex: All
Age: 18+
Code: NCT06072612
Phase 3, Recruiting
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
for
Triple Negative Breast Cancer, Breast Cancer,
Location: Phoenix AZ, Las Vegas NV, Orange CA, Santa Monica CA,
Sponsor: Day One Biopharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT05377996
Phase 1, Phase 2, Recruiting
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
for
Gastrointestinal Stromal Tumor (GIST),
Location: Phoenix AZ, La Jolla CA, Orange CA, Los Angeles CA,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06655246
Phase 1, Recruiting
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
for
Multiple Myeloma
Location: Phoenix AZ, Duarte CA, Stanford CA, San Francisco CA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT05201781
Phase 4, Recruiting
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
for
Solid Tumors With HRAS Alterations,
Location: Phoenix AZ, Tucson AZ, Los Angeles CA, Oklahoma City OK,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06026410
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer
for
Pancreatic Cancer
Location: Phoenix AZ, Houston TX, Charlottesville VA, Hartford CT,
Sponsor: Craig L Slingluff, Jr
Sex: All
Age: 18+
Code: NCT02305186
Phase 1, Phase 2, Recruiting
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
for
Cervical Squamous Cell Carcinoma,
Location: Phoenix AZ, Los Angeles CA, San Antonio TX, Houston TX,
Sponsor: Alentis Therapeutics AG
Sex: All
Age: 18+
Code: NCT07169734
Phase 1, Phase 2, Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
for
Breast Neoplasms, Triple Negative Breast Neoplasms,
Location: Phoenix AZ, Gilbert AZ, Tucson AZ, Las Vegas NV,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06966700
Phase 3, Recruiting
A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
for
High Risk Smoldering Multiple Myeloma (HR-SMM)
Location: Phoenix AZ, St Louis MO, Rochester MN, Atlanta GA,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07393282
Phase 3, Recruiting
New
Conducting Wound, Ostomy, and Continence (WOC) Nurse Telephone Follow-up for Post-discharge Ostomy Patients to Reduce Hospital Readmission
for
Ostomy
Location: Phoenix AZ
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT07879872
Recruiting
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
for
Hormone Receptor Positive HER-2 Negative Breast Cancer,
Location: Phoenix AZ, Irvine CA, Fountain Valley CA,
Sponsor: Puma Biotechnology, Inc.
Sex: All
Age: 18+
Code: NCT06369285
Phase 2, Recruiting
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
for
Ovarian Cancer
Location: Phoenix AZ, Rochester MN, Charleston WV, Cleveland OH,
Sponsor: NX Development Corp
Sex: Female
Age: 18+
Code: NCT05804370
Phase 3, Recruiting
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
for
Advanced Systemic Mastocytosis (AdvSM),
Location: Phoenix AZ, Duarte CA, Los Angeles CA,
Sponsor: Cogent Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT04996875
Phase 2, Recruiting
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
for
Epithelial Ovarian Cancer, Primary Peritoneal,
Location: Phoenix AZ, Tucson AZ, Fullerton CA, Duarte CA,
Sponsor: TORL Biotherapeutics, LLC
Sex: Female
Age: 18+
Code: NCT06690775
Phase 2, Recruiting
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
for
Non-muscle Invasive Bladder Cancer
Location: Phoenix AZ, Queen Creek AZ, Orange CA, Bakersfield CA,
Sponsor: Protara Therapeutics
Sex: All
Age: 18+
Code: NCT05951179
Phase 2, Recruiting
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML